CDMA to bring 2013 Trade Expo to Atlanta in February
NOVI, Mich. — The Chain Drug Marketing Association on Wednesday announced its 87th Annual Trade Expo will take place Feb. 19 to 22 at the Hilton Atlanta in Atlanta.
A “Lunch and Learn” for buyers is planned with Bruce Kneeland, of Epicor Software Solutions, speaking about “How successful Pharmacy Owners use the Front-End to Build Sales and Improve Their Image."
CDMA is owned by more than 100 regional drug chains, independent pharmacies, regional drug wholesalers, specialty distributors and buying groups.
No comments found
Walgreens sues DEA over Florida DC controlled substance ban
WASHINGTON — Walgreens on Thursday filed a suit against the U.S. Drug Enforcement Administration over the agency’s ban on Walgreens’ distribution of controlled substances from a Florida facility, according to a report published by Bloomberg late Thursday evening.
Walgreens charged that the DEA relied "on ‘outdated data’ involving oxycodone to justify suspending distribution of the drugs from its Jupiter, Florida, facility. [Walgreens] asked the court to lift the suspension order," the report read.
Walgreens maintained there was no one allegation made by the DEA that any improper shipment originated from the company’s Jupiter distribution center, or that Walgreens improperly dispensed a controlled substance from one of its pharmacies.
The case is Walgreen Co. v. Holder, 12-1397, U.S. Court of Appeals for the District of Columbia (Washington), according to the report.
For the Bloomberg story, click here.
Walgreens to pay out quarterly dividend of 27.5 cents per share
DEERFIELD, Ill. — The board of directors of Walgreens on Wednesday declared a regular quarterly dividend of 27.5 cents per share, a 22.2% increase over the year-ago dividend. The dividend is payable Dec. 12 to shareholders of record Nov. 12.
Walgreens has paid a dividend in 320 straight quarters (80 years) and has raised its dividend for 37 consecutive years. Over the last five years, Walgreens annual dividend rate has increased from 38 cents per share to $1.10 per share, resulting in a compound annual growth rate of nearly 24%.
No comments found